Invega Paliperidone Extended Release Tablets

SECTION 2: Hazards identification

Emergency overview: PRODUCT INTENDED FOR THERAPUTIC USE ONLY AS PRESCRIBED BY A PHYSICIAN. No exposure to hazardous chemicals is expected in normal handling and administration of product, but may occur if product is misused or damaged: Harmful if swallowed. May be harmful by inhalation. Suspect cancer hazard - risk of cancer depends on duration and level of exposure. Substance is an antipsychotic, and may cause tremors, lack of coordination, and decreased motor activity, there is a potential danger from operating machinery, automobiles, or engaging in other potentially dangerous activities if exposed to this compound. This material is a controlled product under WHMIS.

Potential health effects

Harmful if swallowed. May be harmful by inhalation. Paliperidone has the potential to impair judgement, thinking or motor skills. Palperidone is the major active metabolite of Risperidone.

Principle Routes of Exposure

Eye Contact: Unknown on product Skin contact: Unknown on product. Ingestion: Harmful if swallowed. Inhalation: May be harmful by inhalation. Physico-chemical properties: No hazards resulting from material as supplied. Hazard information: Target Organ(s) central nervous system, cardiovascular system Reproductive effects: Unknown on product. Mutagenic effects: Not mutagenic. Sensitization: Unknown on product. Carcinogenicity rating: This product formulation contains no ingredients listed as carcinogenic through reputable agencies. Signs and symptoms: Unknown on product.

Medical Conditions Generally Aggravated by Exposure

Unknown on product.